Journals / Turkish archives of pediatrics (Online) / 2022 / Cilt: 57 - Sayı: 2

Lymphocyte Subsets in Mild COVID-19 Pediatric Patients

Pages
210–215
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Understanding the answer to the question of why children develop more protective immunity to the virus could be an essential step for developing new treatments.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The reasons for a high prevalence of asymptomatic or mild coronavirus disease (COVID-19) and rare severe disease in children have been explained by non-immune and immune mechanisms.
📊
Key Findings & Data:This study aimed to evaluate the immune system’s response to severe acute respiratory syndrome coronavirus 2 by investigating lymphocyte subsets.
💡
Conclusion & Impact:Understanding the answer to the question of why children develop more protective immunity to the virus could be an essential step for developing new treatments.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: The reasons for a high prevalence of asymptomatic or mild coronavirus disease (COVID-19) and rare severe disease in children have been explained by non-immune and immune mechanisms. This study aimed to evaluate the immune system’s response to severe acute respiratory syndrome coronavirus 2 by investigating lymphocyte subsets. Materials and Methods: This study included 33 coronavirus disease positive children, of whom 12 had mild disease and 21 had an asymptomatic infection as the patient group and 26 age- and gender-matched healthy children as the control group. The demographic information, symptoms, physical examination findings, complete blood count, C-reactive protein (CRP), procalcitonin, and lymphocyte subsets were recorded in all subjects. Results: Leukocyte, lymphocyte, monocyte count, and hemoglobin levels of our pediatric coronavirus disease patients were similar to the control group. Neutrophil was lower in the coronavirus disease cases compared to the control group. CRP and procalcitonin levels of asymptomatic cases were similar to the control group. B cell count, CD8+ T cell count, and CD4/CD8 ratio (dividing the CD4 cell count by the CD8 cell count) ratio were similar in the patient and control groups. Natural killer, T cell, and CD4+ T cell counts were significantly higher in the whole patient group compared to the control group. Conclusion: One reason for mild severe acute respiratory syndrome coronavirus 2 infection in children may be an increase in some lymphocyte subsets such as natural killer cells, T cell, and CD4+ T cell. Understanding the answer to the question of why children develop more protective immunity to the virus could be an essential step for developing new treatments.

🔖

Cite This Article

ARGUN, M., İNAN, D. B., ÖZ, H. T. H., DUYAR, M. O., BAŞARGAN, G., ELMALI, F., ÇELİK, İ. (2022). Lymphocyte Subsets in Mild COVID-19 Pediatric Patients. Turkish archives of pediatrics (Online), Cilt: 57 - Sayı: 2, 210–215. https://ajindex.com/articles/414185

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. . Deng Z, Zhang M, Zhu T, et al. Dynamic changes in peripheral blood lymphocyte subsets in adult patients with COVID-19. Int J Infect Dis. 2020;98:353-358. [CrossRef] 2. Shrestha R, Shrestha L. Coronavirus disease 2019 (Covid-19): a pediatric perspective. JNMA J Nepal Med Assoc. 2020;58(227):525- 532. [CrossRef] 3. Üzel VH, Yılmaz K, Şen V, et al. Evaluation of hematological param- eters of children diagnosed with COVID-19: single-center experi- ence. Turk Arch Pediatr. 2021;56(5):463-468. 4. Çokuğraş H, Önal P. SARS-CoV-2 infection in children. Turk Pediatri Ars. 2020;55(2):95-102. [CrossRef] 5. Hendricks CL, Green RJ. COVID-19 in children: should we be Wor- ried? S Afr Med J. 2020;110(9):864-868. [CrossRef] 6. Chen J, Han T, Huang M, et al. Clinical characteristics of asymp- tomatic carriers of novel coronavirus disease 2019: a multi-center study in Jiangsu Province. Virulence. 2020;11(1):1557-1568. [CrossRef] 7. Munro APS, Faust SN. COVID-19 in children: current evidence and key questions. Curr Opin Infect Dis. 2020;33(6):540-547. [CrossRef] 8. Suratannon N, Dik WA, Chatchatee P. Hagen PM van. COVID-19 in children: heterogeneity within the disease and hypothetical patho- genesis. Asian Pac J Allergy Immunol. 2020;38:170-177. 9. Cavallo F, Rossi N, Chiarelli F. Novel coronavirus infection and chil- dren. Acta Biomed. 2020;91(2):172-176. [CrossRef] 10. Kazancioglu S, Yilmaz FM, Bastug A, et al. Lymphocyte subset alteration and monocyte. Viral Immunol. 2020;00:1-10. 11. Gan J, Li J, Li S, Yang C. Leucocyte subsets effectively predict the clinical outcome of patients With COVID-19 pneumonia: a retro- spective case-control study. Front Public Health. 2020;8:299. [CrossRef] 12. Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. SSRN Journal. 2020;53:1689-1699. [CrossRef] 13. Jiang M, Guo Y, Luo Q, et al. T cell subset counts in peripheral blood can be used as discriminatory biomarkers for diagnosis and sever- ity prediction of COVID-19. J Infect Dis. 2020;222(2):198-202. [CrossRef] 14. Lu Q, Wang Z, Yin Y, Zhao Y, Tao P, Zhong P. Association of periph- eral lymphocyte and the subset levels With the progression and mortality of COVID-19: a systematic review and meta-analysis. Front Med (Lausanne). 2020;7:558545. [CrossRef] 15. Sun Y, Dong Y, Wang L, et al. Characteristics and prognostic fac- tors of disease severity in patients with COVID-19: the Beijing expe- rience. J Autoimmun. 2020;112:102473. [CrossRef]